DEVELOPING: Leucovorin Autism Link Sparks Widespread Skepticism Among Scientists and Parents

BREAKING NEWS The Trump administration has sparked widespread skepticism among scientists and parents after suggesting that leucovorin, a cancer treatment drug, may have benefits for children with autism. According to sources, the White House held a press conference on Monday where President Trump and his deputies claimed that Tylenol is linked to autism and encouraged the use of leucovorin as a potential treatment. However, many experts and families are questioning the validity of these claims. Leucovorin, also known as folinic acid, is a prescription medication used to prevent and treat certain types of cancer. While some parents are excited about the possibility of a new autism treatment, others are expressing concern and skepticism. "I think that this entire thing has been a bit misleading," said Caitee Donovan, whose 17-month-old daughter was diagnosed with autism. "I'm not sure what to believe anymore." The Trump administration's claims have been met with criticism from the scientific community, with many experts calling for more research before leucovorin is touted as an autism treatment. This is a developing story and we will provide updates as more information becomes available. STAY TUNED FOR FURTHER UPDATES Note: This breaking news article is based on confirmed facts and sources, but the situation is rapidly evolving. We will continue to provide updates as new information becomes available. *This is a developing story. Updates will be provided as more information becomes available. Based on reporting from Npr.*